Sign in

CIK 0000886163 · Large accelerated filer

LIGAND PHARMACEUTICALS INC

Sign in to watch
Tickers
LGND LGNDZ LGNXZ LGNYZ LGNZZ
Exchange
Nasdaq, OTC
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
770160744
Phone
858-550-7500
Business address
3911 SORRENTO VALLEY BLVD, SUITE 110, SAN DIEGO, CA, 92121
Former names
LIGAND PHARMACEUTICALS

Securities

  • LGND Common Stock Nasdaq
  • LGNDZ Common stock OTC
  • LGNXZ Common stock OTC
  • LGNYZ Common stock OTC
  • LGNZZ Common stock OTC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$6,585,411
in 7 filings, $4.5M under 10b5-1 plans

Net −$6,585,411. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Reardon Andrew −$4.5M CLO & Secretary sold 32% of stake
  2. Aryeh Jason −$1.7M Director sold 5% of stake
  3. Zimmermann Martine −$342K Director sold 24% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2017-12-28 Korenberg Matthew E VP, Finance and CFO Shares withheld for taxes −1,530 $138.66 $212K 10,367
2017-12-28 FOEHR MATTHEW W President and COO Grant or award +5,695 101,465
2017-12-28 FOEHR MATTHEW W President and COO Shares withheld for taxes −2,971 $138.66 $412K 98,494
2017-12-28 HIGGINS JOHN L Chief Executive Officer Grant or award +9,965 151,249
2017-12-28 HIGGINS JOHN L Chief Executive Officer Shares withheld for taxes −5,199 $138.66 $721K 146,050
2017-12-28 Berkman Charles S VP, Gen. Counsel & Secretary Grant or award +2,847 27,270
2017-12-28 Berkman Charles S VP, Gen. Counsel & Secretary Shares withheld for taxes −1,175 $138.66 $163K 26,095
2017-12-26 Davis Todd C Director Gift −74 70,733
2017-12-20 Sabba Stephen L Director Sale −925 $137.25 $127K 26,985
2017-11-17 Aryeh Jason Director Sale −24,400 $140.22 $3.4M 90,251
2017-11-17 HIGGINS JOHN L Chief Executive Officer Sale −2,258 $140.34 $317K 141,284
2017-11-17 LAMATTINA JOHN L Director Option exercise +4,000 $10.12 $40K 24,956
2017-11-17 LAMATTINA JOHN L Director Sale −4,000 $139.79 $559K 20,956
2017-11-17 LAMATTINA JOHN L Director Option exercise · Non-Qualified Stock Option (right to buy) −4,000 3,335
2017-11-17 Korenberg Matthew E VP, Finance and CFO Sale −6,559 $142.63 $936K 8,147
2017-11-16 KOZARICH JOHN W Director Sale −5,000 $141.71 $709K 35,649
2017-11-16 HIGGINS JOHN L Chief Executive Officer Sale −5,269 $142.53 $751K 143,542

Page 55 of 55 · 1,097 trades